Book description
This comprehensive and critical review of current and established
treatment modalities for malignant liver tumors is designed to help you
sort through the proliferation of competitive approaches and choose the
best treatment options for your patient. Dr. Clavien and his
contributors consider all the options - radiological, surgical,
pharmaceutical, and emerging/novel therapies - and help you find the
best single or combined therapy.
Building on the success of the previous edition, this extremely
thorough revision:
- features a new section on Guidelines for Liver Tumors, where you
will find specific strategies for treating common liver
malignancies; the guidelines were prepared by the Associate
Editors and take into account national and international society guidelines
- reflects actual practice by taking a multidisciplinary approach,
with contributions from international experts who have extensive
experience with this patient population
- achieves comprehensive and balanced coverage by having each
chapter reviewed by the Editor, Deputy Editor, two Associate
Editors, and at least one external reviewer
- includes 16 new chapters that cover liver anatomy, histologic
changes in the liver, epidemiology and natural history of HCC, CCC
and colorectal liver metastases, strategies of liver resection,
and economic aspects as well as novel therapies
- facilitates the kind of daily interaction among hepatologists,
hepatic surgeons, medical oncologists, radiotherapists, and
interventional radiologists that is essential when treating
patients with complex liver malignancies
In 44 chapters organized into six major sections, the book covers the
full range of liver tumors. The perfect blend of evidence and
experience, Malignant Liver Tumors: Current and Emerging Therapies,
3rd Edition, illuminates the path to better patient
care.
Editor-in-Chief:
Pierre-Alain Clavien
Department of Visceral and Transplant Surgery, University
Hospital Zurich, Switzerland
Associate Editors:
Tadatoshi Takayama, Second Department
of Surgery, Faculty of Medicine, University of Tokyo, Japan
CM Lo, Liver Transplant Centre, Queen Mary Hospital, 102
Pokfulam Road, Hong Kong
R. Chari, Associate Professor of Surgery and Cancer Biology,
Division Chief of Hepatobillary Surgery and Liver Transplantation,
Staff Surgeon, Veterans Affairs Medical Center, Vanderbilt University
Medical Center, Nashville, USA
M. Morse, Associate Professor, Duke University Medical School,
Durham, USA
J. Llovet, Barcelona-Clínic Liver Cancer Group, Liver Unit,
Institut d'Investigacions Biomédiques August Pi I Sunyer, Hospital
Clínic, University of Barcelona, Catalonia, Spain
